Lacktman, Ferrante Discuss Proposed Legislation Aimed at Combatting Substance Abuse
March 5, 2018
mHealthIntelligence
Partner Nate Lacktman and Senior Counsel Thomas Ferrante were quoted in an mHealthIntelligence article, “Congress Turns to Telemedicine to Take on Substance Abuse Epidemic,” about two bills pending in Congress that would ease restrictions on the prescribing of controlled substances to patients in telehealth-based drug treatment programs.
Lacktman and Ferrante said current federal law does not per se prohibit the use of telemedicine to prescribe controlled substances, and that a provider may do so if he or she has conducted at least one in-person exam of the patient or meets a ‘practice of telemedicine’ exception to the law’s in-person exam requirement. The problem, they said, is that the ‘practice of telemedicine’ exceptions in the law are very narrow, highly technical, and simply outdated.
“The practice of telemedicine has evolved exponentially in the decade since the [federal law] was passed, and the regulations fail to account for how legitimate telemedicine services are delivered today,” the pair said. “For that reason, the exceptions do not easily align with direct-to-patient service models frequently sought by patients in areas such as telepsychiatry or substance use disorder treatment. In addition, there is a nationwide shortage of psychiatrists and board certified substance abuse addiction specialists, coupled with the nation’s tragic opioid crisis, making telemedicine services an attractive resource.”
Lacktman and Ferrante’s quotes were sourced from their recent Health Care Law Today blog post, which can be found here.
Lacktman and Ferrante said current federal law does not per se prohibit the use of telemedicine to prescribe controlled substances, and that a provider may do so if he or she has conducted at least one in-person exam of the patient or meets a ‘practice of telemedicine’ exception to the law’s in-person exam requirement. The problem, they said, is that the ‘practice of telemedicine’ exceptions in the law are very narrow, highly technical, and simply outdated.
“The practice of telemedicine has evolved exponentially in the decade since the [federal law] was passed, and the regulations fail to account for how legitimate telemedicine services are delivered today,” the pair said. “For that reason, the exceptions do not easily align with direct-to-patient service models frequently sought by patients in areas such as telepsychiatry or substance use disorder treatment. In addition, there is a nationwide shortage of psychiatrists and board certified substance abuse addiction specialists, coupled with the nation’s tragic opioid crisis, making telemedicine services an attractive resource.”
Lacktman and Ferrante’s quotes were sourced from their recent Health Care Law Today blog post, which can be found here.
Related News
July 11, 2025
In the News
Foley Attorneys Assess Critical IP Considerations for Emerging Medical Device Companies
Foley & Lardner LLP attorneys Shabbi Khan, Nate Beaver, Austin Kim, and Jeff Simon authored the Med Device Online article, "Critical Considerations For IP & Patents For Emerging Medical Device Companies."
July 11, 2025
In the News
David Morris Featured for Arrival to Foley's Salt Lake City Office
Foley & Lardner LLP partner David Morris is highlighted across legal press for his recent arrival to the firm.
July 10, 2025
In the News
Ann Marie Uetz Comments on Automotive Supply Chain Approach to Evolving Tariff Environment
Foley & Lardner LLP partner Ann Marie Uetz shared perspective from the automotive supply chain amid the evolving trade environment in the Crain's Detroit article, "Ford, Stellantis tighten terms on suppliers as tariff costs add up."